Home › Allergan Board Turns Down Valeant Takeover Offer
 

Keywords :   


Allergan Board Turns Down Valeant Takeover Offer

2014-05-12 14:36:03| Biotech - Topix.net

Botox maker Allergan is rejecting a takeover bid from Valeant Pharmaceuticals, saying that the unsolicited $46 billion offer undervalues the company and carries significant risk.

Tags: board offer turns takeover

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
04.07Atlantic Tropical Weather Outlook
04.07Hurricane Beryl Graphics
04.07Hurricane Beryl Public Advisory Number 24A
04.07Summary for Hurricane Beryl (AT2/AL022024)
04.07Eastern North Pacific Tropical Weather Outlook
04.07 Mankiewicz Supplies Eye-catching Coatings for the CLAAS Anniversary Combine Harvester
04.07AR/VR panel shipments to increase 12% in 2024
04.07Astro Malaysia presents results for quarter ended 30 April 2024
More »